Search research articles
Contact Us
Filters
Showing results (141-150 of 317) with videos related to
Page
of 32
Sort By:
Cancer Treatment Reports
|
June 1, 1979
Amino acid manipulations in cancer treatment: a perspective from the National Cancer Institute Workshop
F M Muggia, R Catane, J Douros, et al.
Anti-Cancer Drugs
|
January 7, 1999
Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: tolerance and activity in ovarian cancer
T Safra, S Jeffers, J Sorich, et al.
Cancer Treatment Reports
|
November 1, 1979
Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26
D F Chiuten, F M Muggia, R K Johnson
Lancet (London, England)
|
August 28, 1971
Bone-marrow examination in 100 consecutive patients with bronchogenic carcinoma
H H Hansen, F M Muggia, O S Selawry
Annals of Internal Medicine
|
November 1, 1985
Ovarian cancer: new therapeutic concepts, renewed optimism
F M Muggia, M J Piccart, J L Speyer
Anticancer Research
|
July 1, 1988
A new look at radionuclides therapy in metastatic disease of bone (review and prospects)
S I Kim, D C Chen, F M Muggia
Cancer Treatment Reports
|
August 1, 1978
Problems in the development of cytotoxic moieties linked to hormones
M E Lippman, J C Heuson, F M Muggia
Seminars in Oncology
|
December 1, 1981
The Cancer Therapy Evaluation Program of the National Cancer Institute
F M Muggia, S K Carter, J S Macdonald
Cancer Chemotherapy Reports
|
December 1, 1971
Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819)
F M Muggia, O S Selawry, H H Hansen
Antibiotics and Chemotherapy
|
January 1, 1978
New anticancer drugs
F M Muggia, V H Bono, V T DeVita
Page
of 32
Search research articles
Search
Showing results (141-150 of 317) with videos related to
Sort By:
Page
of 32
Cancer Treatment Reports
|
June 1, 1979
Amino acid manipulations in cancer treatment: a perspective from the National Cancer Institute Workshop
F M Muggia, R Catane, J Douros, et al.
Anti-Cancer Drugs
|
January 7, 1999
Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: tolerance and activity in ovarian cancer
T Safra, S Jeffers, J Sorich, et al.
Cancer Treatment Reports
|
November 1, 1979
Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26
D F Chiuten, F M Muggia, R K Johnson
Lancet (London, England)
|
August 28, 1971
Bone-marrow examination in 100 consecutive patients with bronchogenic carcinoma
H H Hansen, F M Muggia, O S Selawry
Annals of Internal Medicine
|
November 1, 1985
Ovarian cancer: new therapeutic concepts, renewed optimism
F M Muggia, M J Piccart, J L Speyer
Anticancer Research
|
July 1, 1988
A new look at radionuclides therapy in metastatic disease of bone (review and prospects)
S I Kim, D C Chen, F M Muggia
Cancer Treatment Reports
|
August 1, 1978
Problems in the development of cytotoxic moieties linked to hormones
M E Lippman, J C Heuson, F M Muggia
Seminars in Oncology
|
December 1, 1981
The Cancer Therapy Evaluation Program of the National Cancer Institute
F M Muggia, S K Carter, J S Macdonald
Cancer Chemotherapy Reports
|
December 1, 1971
Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819)
F M Muggia, O S Selawry, H H Hansen
Antibiotics and Chemotherapy
|
January 1, 1978
New anticancer drugs
F M Muggia, V H Bono, V T DeVita
Page
of 32